论文部分内容阅读
目的:研究探讨利奈唑胺运用于治疗儿童重症革兰阳性菌感染的临床效果。方法:通过对经验用药治疗无效总结的基础之上,引进了利奈唑胺进行重症革兰阳性菌感染的治疗。结果:本文观察的30例患有重症革兰阳性菌感染的患儿经过静脉滴注利奈唑胺,在进行为期10~14d的治疗后,病情得到了明显的好转。结论:利奈唑胺运用于治疗儿童重症革兰阳性菌感染中具有非常好的效果,在一定范围内可以推广使用。
Objective: To study the clinical effect of linezolid in the treatment of severe gram-positive infections in children. METHODS: Linezolid was introduced for the treatment of severe Gram-positive bacterial infections on the basis of an invalid summary of empirical medication. Results: The infants treated with intravenous infusion of linezolid in 30 patients with severe Gram-positive bacteria observed in this study showed a significant improvement after 10 to 14 days of treatment. Conclusion: Linezolid is very effective in the treatment of severe gram-positive infections in children and can be widely used in a certain range.